Loading
₹2,628.00
−127.00−4.61%today
Market closed · 7 Oct, 3:30 pm
−4.10%over 1 year
Today's range
₹2,613.30₹2,760.00
52-week range
₹2,088.10₹3,120.70
Revenue and net profit in ₹ crore, consolidated where the company reports both.
| Year | Revenue | Net profit | Margin | EPS (₹) |
|---|---|---|---|---|
| FY26 | 3,808 | 1,036 | 27.2% | 61.15 |
| FY25 | 3,726 | 928 | 24.9% | 54.76 |
| FY24 | 3,442 | 590 | 17.1% | 34.83 |
| FY23 | 3,226 | 611 | 18.9% | 36.05 |
As of Jun 2026, as a share of all the company's shares.
| Holder | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 75.00% | 75.00% | 75.00% | 75.00% |
| FIIs | 4.79% | 4.62% | 4.64% | 4.80% |
| DIIs | 7.80% | 7.68% | 7.70% | 7.75% |
| of which mutual funds | 4.87% | 4.73% | 4.77% | 5.05% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 12.41% | 12.69% | 12.66% | 12.45% |
From the company's quarterly filings with NSE. FIIs are foreign institutions; DIIs are Indian ones such as mutual funds, insurers and banks.
Healthcare companies in the Nifty 500 closest in size.
| Company | Price (₹) | Change | Market cap (₹ cr) |
|---|---|---|---|
| Abbott India Ltd.ABBOTINDIA | 26,100.00 | −0.06% | 55,461 |
| Gland Pharma Ltd.GLAND | 3,159.00 | +5.09% | 52,127 |
| Anthem Biosciences Ltd.ANTHEM | 887.05 | −0.37% | 49,988 |
| Ipca Laboratories Ltd.IPCALAB | 1,929.00 | −0.85% | 48,940 |
| Ajanta Pharmaceuticals Ltd.AJANTPHARM | 3,570.00 | −0.10% | 44,610 |
| Glaxosmithkline Pharmaceuticals Ltd.GLAXO · this stock | 2,628.00 | −4.61% | 44,520 |
| Emcure Pharmaceuticals Ltd.EMCURE | 1,920.00 | −0.12% | 36,424 |
Price and volume from NSE; key figures and results from Yahoo Finance; shareholding and corporate actions from the company's NSE filings. Figures can run behind the exchange. For information only, not a recommendation to invest.